Timing of Breast Cancer Drug  Affects Cardiac Risk: Study
306233
THURSDAY, July 5 (HealthDay News) -- New research suggests that the timing of when a woman receives the breast cancer drug Herceptin can influence its effect on her heart.
191821
NEW YORK  - New research provides more  evidence that childbearing factors, especially those related to  a first pregnancy, influence a woman's risk of breast cancer.
412300
The risk factors for breast cancer start early in a woman&#39;s life, even before birth, according to a major new study. High birth weight, a growth spurt between the ages of 8 and 14, and being a tall, thin adolescent
216909
A new way to accurately predict how individual breast cancer patients will react to the anticancer drug trastuzumab (Herceptin) has been identified by researchers at the Texas MD Anderson Cancer Center, in Houston.
433330
Women with a high risk of breast  cancer are declining to take tamoxifen because they are afraid  of side-effects, even though the drug can protect them from the  cancer, researchers reported on Tuesday.
12453
Childbearing factors, particularly those related to a first pregnancy, can influence a woman&#39;s risk of developing breast cancer, according to a study published in the Nov. 1 issue of the International Journal
506934
A popular class of blood pressure medicines may double a woman&#39;s risk of dying of heart disease, especially when given in certain combinations, a large study out today indicates.
629612
Women with a high risk of breast  cancer are declining to take tamoxifen because they are afraid  of side effects, even though the drug can protect them from the  cancer, researchers reported on Tuesday.
156055
TUESDAY, Feb. 13 (HealthDay News) -- Switching to newer breast cancer drugs, called aromatase inhibitors, after two to three years of treatment with tamoxifen may extend disease-free survival and slightly reduce the risk of death in women who've been treated for early stage disease, an international study finds.
50781
Concerns about side effects discourage many women at high risk for breast cancer from taking tamoxifen, says a study in the Dec. 14 issue of the Journal of Clinical Oncology.
617501
HONOLULU  - The bones of breast cancer patients tend to age prematurely as a result of chemotherapy and aromatase inhibitor therapy, according to research reported at the American Society for Bone and Mineral Research meeting this week.
213549
New research provides more evidence that childbearing factors, especially those related to a first pregnancy, influence a woman's risk of breast cancer.
133597
TUESDAY, Feb. 6 (HealthDay News) -- The U.S. Food and Drug Administration has approved a test designed to predict the chances of breast cancer returning or spreading within five to 10 years after a woman's initial cancer.
193008
Two recent studies that suggested oral contraceptives reduced a woman&#39;s risk of heart disease and cancer seemed to take conventional wisdom and stand it on its head.
456262
TUESDAY, June 5 (HealthDay News) -- Hot flashes may act as positive sign for women taking drug treatment for early stage breast cancer, a new study suggests.
13553
Post-menopausal women diagnosed with early-stage hormone-receptor (HR) positive breast cancer might be better off taking the drug anastrozole (Arimidex - brand name
498000
The type of progestin used in hormone therapy for menopausal women could affect heart attack severity, says a Wake Forest University Baptist Medical Center study on monkeys.